Mutual Funds Commodities Research Tax Planning IPO Our Team Contact Us  
Google
Web www.equitybulls.com
Research

| More

Solar Industries - Improves operational performance - ICICI Securities

Posted On: 2020-11-18 02:18:09 (Time Zone: Arizona, USA)


Solar Industries' (SOIL) delivered a beat on standalone as well as consolidated revenue and EBITDA estimates for Q2FY21. EBITDA margins were ~200bps higher than expected in standalone as well as overseas operations. Standalone gross margins continue to expand (up 300bps QoQ in Q2FY21) following a 400bps expansion witnessed in Q1FY21. Standalone revenues are up 6% YoY despite a muted housing and infra segment growth. Large part of the operational beat can be explained by 32% YoY increase in overseas and export operations (catering to overseas). Two contracts in the current quarter - i) multimodal hand grenade (Rs4.1bn) and ii) with Singareni collieries (SCCL) worth Rs4.5bn - helped replenish the defence and mining orderbooks respectively. Upgrade to HOLD from REDUCE with a revised target price of Rs1,006 (previously: Rs 924/share).

- Standalone revenues take support of exports, margins continue to surprise. Gross margins at 41% were at 5-6-year high. This is despite no significant tailwind from the trade and infra segments, the traditional margin contributors. Higher exports would have driven margin trends in the standalone segment. Buildup in trade receivables (Rs550mn) and working capital investment in H1FY21 (Rs840mn) comes as a negative surprise.

- Overseas business turnaround aided topline/margins. Consolidated revenues increased 16% YoY. This has been helped by 35% YoY growth in subsidiary revenues. We would continue to highlight the significant triggers towards profitability improvement that overseas operations exercise. What stands out from FY20 annual report analysis is PAT loss of ~Rs800mn in South Africa and Australia combined. Excluding these two locations, overseas business PAT was almost flat YoY at Rs1.3bn. Despite business turbulence in Turkey (further impacted by currency depreciation), the turnaround across new locations amidst global business tailwinds augurs well for SOIL profitability. The translation losses continue to get recorded as a part of Other Comprehensive Income (OCI) - Rs 167mn of OCI losses were seen in Q2FY21. Also, despite improvement in revenue and profitability, the operations continues to draw working capital support.

- Multimodal hand grenade order helped defence orderbook. The defence orderbook expanded to Rs7bn from Rs3bn QoQ. Defence revenues are also seen to be getting back into growth trajectory with ~Rs804mn of execution in H1FY21. Higher defence execution can lead to margins exceeding our expectations. SOIL has been highlighting: i) successful test of Pinaka rockets (integrated by SOIL) by Indian Army, and ii) prospective order inflow form multimodal hand grenade.

- Upgrades to HOLD from Reduce. As we factor-in higher margin possibility from overseas business, the key execution challenge for the company will be to offset the weakness in coal (structural) and trade and infra (GoI budget-driven) segments. We value SOIL at 26x FY22E P/E.

Shares of SOLAR INDUSTRIES INDIA LTD. was last trading in BSE at Rs.978.05 as compared to the previous close of Rs. 1003.1. The total number of shares traded during the day was 1486 in over 282 trades.

The stock hit an intraday high of Rs. 1005.75 and intraday low of 978.05. The net turnover during the day was Rs. 1472672.


Source: Equity Bulls

Click here to send ur comments or to feedback@equitybulls.com


Disclaimer:The article above is a gist / extract of the original report prepared by the research firm / brokerage firm. This article is not to be considered as an offer to sell or a solicitation to buy any securities. This article is meant for general information only. www.equitybulls.com, its employees or owners or the research firms, its employees or owners won't be responsible for any liability that may arise from information, errors or omissions in these articles. www.equitybulls.com or its employees or owners / the research firms or its employees or clients or owners may from time to time hold positions in securities referred in this article. For detailed research reports, please contact the concerned research firm directly.





Other Headlines:

Maintain ADD on Symphony - Domestic in line; RoW improving - HDFC Securities

Maintain ADD on Multi Commodity Exchange - Taking a pause; recovery awaited - HDFC Securities

Maintain ADD on DCB Bank - Provisioning cushion emerges ahead of expectations - HDFC Securities

Maintain BUY on Birla Corporation - Margin buoyancy continues - HDFC Securities

ADD on SRF - Returning to normalcy - HDFC Securities

HDFC Securities - Maintain BUY on UltraTech Cement - Solid show!

Ajanta Pharma (Initiating Coverage) - Gearing for the next leap - HDFC Securities

BUY on SBI Life Insurance - Growth returns - HDFC Securities

Kajaria Ceramics (Initiating Coverage) - Galloping ahead - HDFC Securities

UltraTech Q3 FY21 - YES Securities

HDFC Life Q3 FY21 - YES Securities

SBI Life - Q3 FY21 - YES Securities

Aavas Financiers Q3 FY21 - Conference Call Takeaways - YES Securities

Birla Corp Q3 FY21 - YES Securities

ADD on Reliance Industries - Sailed through the tough times! - HDFC Securities

Grasim Industries - Aspiring for strong no.2 position in paints - ICICI Securities

Kewal Kiran Clothing - Better execution with flat EBITDA YoY - ICICI Securities

Mphasis - DXC will continue to be key in the near term - ICICI Securities

HDFC Securities: Indian Chemical Sector (Sector Update) - Steering well through the pandemic!

UltraTech Cement - Earnings upgrade continues; ripe for rerating - ICICI Securities

Multi Commodity Exchange of India - Lower turnover impacted operating performance - Q3FY21 - ICICI Securities

SBI Life Insurance Company - Strong performance, attractive valuations (<2 FY23 P/EV) - ICICI Securities

Biocon Limited - Slow recovery in biosimilars - ICICI Securities

HDFC Life Insurance Company - Not only - but also - about protection - ICICI Securities

DCB Bank - Gradually approaching normalcy - ICICI Securities

Aurobindo Pharma - Approval for 3 products under PLI Scheme - ICICI Securities

Yes Bank - Aggravating asset quality fears outweigh operating performance turnaround - ICICI Securities

JSW Steel - Peak margins expected in Q4FY21 - ICICI Securities

Aavas Financiers - Quality intact; premium to sustain - ICICI Securities

Supreme Industries - Q3FY21 First Cut - ICICI Direct

Polycab India Ltd - Q3FY21 First Cut - ICICI Direct

DCB Bank - Q3FY21 First Cut - ICICI Direct

Q3FY21 Result update - Symphony Ltd. - ICICI Direct

Ultratech Cement - Q3FY21 First Cut - ICICI Direct

Oberoi Realty - Q3FY21 First Cut - ICICI Direct

HDFC Life Insurance - Q3FY21 First Cut - ICICI Direct

SRF Limited - Chemical biz's good performance may continue - ICICI Securities

Multi Commodity Exchange of India - Lower turnover impacted operating performance - ICICI Securities

Q3FY21 Company update - Zensar Technologies - ICICI Direct

JSW Steel - Q3FY21 First Cut - ICICI Direct

Q3FY21 Result update - Biocon Ltd - ICICI Direct

Symphony Ltd - Q3FY21 First Cut - ICICI Direct

Crompton Greaves Consumer Electricals - Q3FY21 First Cut - ICICI Direct

Q3FY21 Result update - Bajaj Finserv - ICICI Direct

Q3FY21 Result update - Bajaj Auto - ICICI Direct

Quant Pick - Hero MotoCorp - ICICI Direct

Company update - Cyient Ltd - Q3FY21 - ICICI Direct

Covid Recovery Pulse - Auto retail taper off in new year 2021 - ICICI Direct

Q3FY21 Result update - Asian Paints - ICICI Direct

Company update - Mphasis Ltd - Q3FY21 - ICICI Direct



Website Created & Maintained by : Chennai Scripts
West Mambalam, Chennai - 600 033,
Tamil Nadu, India

disclaimer copyright © 2005 - 2020